Patents by Inventor Wengian An

Wengian An has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potassium channel interacting polypeptides and uses thereof
    Patent number: 7041795
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: May 9, 2006
    Assignees: Millennium Pharmaceuticals, Inc, Wyeth
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wengian An
  • Cloning and characterization of a cdc15-like adaptor protein (CD2BP1)
    Patent number: 6444439
    Abstract: A human CD2 cytoplasmic tail binding protein, CD2BP1, is described, as well as the nucleic acids encoding the protein. Also described are expression vectors and recombinant host cells comprising nucleic acids encoding the CD2BP1 protein, and methods of use for the CD2BP1 protein and nucleic acids encoding the CD2BP1 protein.
    Type: Grant
    Filed: January 13, 1998
    Date of Patent: September 3, 2002
    Assignee: Dana-Farber Cancer Institute
    Inventors: Jing Li, Kazuhisa Nishizawa, Wengian An, Ellis L. Reinherz
  • Potassium channel interactors and uses therefor
    Patent number: 6369197
    Abstract: The invention provides isolated nucleic acids molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. The invention still further provides isolated PCIP proteins, fusion proteins, antigenic peptides and anti-PCIP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: April 9, 2002
    Assignees: Millennium Pharmaceuticals, Inc., American Home Products Corp.
    Inventors: Kenneth Rhodes, Maria Betty, Huai-Ping Ling, Wengian An